Underuse of oral anticoagulants in privately insured patients with atrial fibrillation: A population being targeted by the IMplementation of a randomized controlled trial to imProve treatment with oral AntiCoagulanTs in patients with Atrial Fibrillation (IMPACT-AFib)
Sana M. Al‐Khatib, Sean D. Pokorney, Hussein R. Al‐Khalidi, Kevin Haynes, Crystal Garcia, David Martin, Jennifer C. Goldsack, Thomas Harkins, Noelle M. Cocoros, Nancy D. Lin, Hana Lipowicz, Debbe McCall, Vinit Nair, Lauren E. Parlett, Cheryl N. McMahill‐Walraven, Richard Platt, Christopher B. Granger
Topics & Concepts
MedicineAtrial fibrillationRandomized controlled trialWarfarinRivaroxabanPopulationOral anticoagulantIntensive care medicineInternal medicineCardiologyEnvironmental healthAtrial Fibrillation Management and OutcomesVitamin K Research StudiesVenous Thromboembolism Diagnosis and Management